Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic Umbilical Cord MSCs for Knee Osteoarthritis
NCT03800810Phase 1Unknown
- Sponsor
- Universitas Indonesia
- Start
- May 2015
- Primary completion
- May 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised trial of human umbilical cord mesenchymal stem cells in osteoarthritis (OA) (3 arms), sponsored by Universitas Indonesia. Primary endpoints: Cartilage T2 map score at 6 months, IKDC score at 3 months and 2 more. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03800810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03800810.